_converted.avif)
Two-time NBA MVP Giannis Antetokounmpo didn't just sign an endorsement deal with Superpower — he found something in his own results that made the investment personal.
Superpower is a preventative health membership that tests 100+ biomarkers for $199 a year — delivering the kind of comprehensive blood work previously reserved for professional athletes, executives and concierge medicine clients paying 2–3x the average monthly rent.
A standard annual physical checks 10–15 basic markers and only acts after symptoms appear. Superpower runs deep on cardiovascular health, inflammation, hormone function, metabolic markers and nutrient levels — surfacing the silent risks that routine care consistently misses. To date, 60% of Superpower members have uncovered something their regular doctor never flagged.
Here's what makes this partnership different from a typical athlete endorsement: Giannis actually used the product — and it found things.
Despite having access to one of the most advanced medical teams in professional sport, his Superpower panel revealed elevated cardiovascular risk markers and a Vitamin D level deep in the deficient range. If the world's most optimised body still has hidden gaps, the average person almost certainly does too.
With recent knee and calf injuries behind him and heading into his 14th NBA season, understanding the biomarkers that drive recovery isn't optional for Giannis — it's career longevity. That's what turned this from a brand deal into a personal conviction.
"When I found Superpower, I saw a platform that could give people the same kind of testing, information and support I have to stay on top of my health. This is a level of care that more people should have access to without needing to worry about excessive costs."
— Giannis Antetokounmpo
Giannis grew up in Greece without access to basic healthcare. His family couldn't afford doctors, let alone comprehensive testing. That context makes his backing of a $199-a-year diagnostic platform more than a portfolio move — it's a mission that's been decades in the making.
Superpower was built on exactly that premise: that the gap between elite athlete healthcare and what everyone else gets is too wide, and that comprehensive biomarker testing shouldn't require a specialist referral, an insurance battle or a luxury wellness membership most people can't afford.
Superpower membership includes a 100+ biomarker blood panel, AI-powered health insights, personalised care protocols and 24/7 access to a clinical team. Testing is available at over 2,000 in-lab locations across the US, with at-home blood draws also available.
The platform has raised over $40 million — including a Series A led by Forerunner Ventures — and counts Steve Aoki, Vanessa Hudgens and leading clinicians among its growing investor roster.
Giannis isn't alone. A clear pattern is emerging across elite sport — the endorsement era is over. Athletes are taking equity, shaping strategy and building the companies they back from the inside.
Tom Brady co-chairs Future's board and invested in digital health platform eMed. Serena Williams backs women's health platforms Midi Health and Teal Health through Serena Ventures. Novak Djokovic joined General Atlantic as a Global Strategic Advisor after placing bets across biotech and wellness. Maria Sharapova holds equity in Therabody, Tonal and Bala while serving on Moncler's board.
The through-line is consistent: elite athletes understand performance, recovery and longevity better than almost anyone. That expertise has become a legitimate investment thesis — and health is where the smartest money in sport is going.
Superpower and Giannis are the latest proof that the future of preventative healthcare isn't being built in hospitals. It's being built by the people who have the most to lose from getting it wrong.
Learn more at superpower.com
.png)
.png)
_converted.avif)